Amdocs Limited (NASDAQ:DOX) Shares Acquired by Portfolio Design Labs LLC

Portfolio Design Labs LLC increased its position in Amdocs Limited (NASDAQ:DOXFree Report) by 294.6% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 13,650 shares of the technology company’s stock after acquiring an additional 10,191 shares during the period. Portfolio Design Labs LLC’s holdings in Amdocs were worth $1,162,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Janus Henderson Group PLC lifted its holdings in shares of Amdocs by 1.7% in the third quarter. Janus Henderson Group PLC now owns 6,625,875 shares of the technology company’s stock valued at $579,632,000 after buying an additional 111,357 shares during the period. Pzena Investment Management LLC lifted its holdings in shares of Amdocs by 12.3% in the third quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company’s stock valued at $556,700,000 after buying an additional 696,136 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in shares of Amdocs by 36.6% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,175,790 shares of the technology company’s stock valued at $277,818,000 after purchasing an additional 851,022 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of Amdocs by 0.8% during the third quarter. Wellington Management Group LLP now owns 2,136,932 shares of the technology company’s stock valued at $186,939,000 after purchasing an additional 16,580 shares during the last quarter. Finally, Pacer Advisors Inc. lifted its holdings in shares of Amdocs by 7.4% during the fourth quarter. Pacer Advisors Inc. now owns 1,815,675 shares of the technology company’s stock valued at $154,587,000 after purchasing an additional 125,654 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Stock Up 0.6 %

Shares of Amdocs stock opened at $86.32 on Wednesday. The stock has a 50-day moving average price of $85.90 and a 200 day moving average price of $86.48. The company has a market cap of $9.74 billion, a P/E ratio of 20.03, a P/E/G ratio of 1.41 and a beta of 0.71. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22. Amdocs Limited has a 1 year low of $74.41 and a 1 year high of $94.04.

Amdocs (NASDAQ:DOXGet Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. As a group, analysts expect that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Sunday, April 20th. Investors of record on Monday, March 31st will be paid a $0.527 dividend. This is an increase from Amdocs’s previous quarterly dividend of $0.48. This represents a $2.11 annualized dividend and a yield of 2.44%. The ex-dividend date of this dividend is Monday, March 31st. Amdocs’s dividend payout ratio is currently 44.55%.

Analyst Ratings Changes

DOX has been the subject of several analyst reports. Oppenheimer upped their target price on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. StockNews.com raised Amdocs from a “buy” rating to a “strong-buy” rating in a report on Wednesday, February 5th. Finally, Barclays reduced their target price on Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a report on Thursday, November 14th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Amdocs has an average rating of “Buy” and a consensus price target of $101.20.

View Our Latest Stock Analysis on Amdocs

Amdocs Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Further Reading

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.